← Back to All Stocks

ImmunoPrecise Antibodies Ltd. (IPA) Analysis

Generated on: 2025-08-20 20:06:56 UTC
All stock prices are delayed.
Use of this site does not constitute financial advice.

Analysis Values

Current Price
$2.77
Predicted Price
$2.17
Expected Return
-18.78%
Confidence Score
0.86
RSI (14)
81.54 (sell)
MACD
0.26
Volume
1,610,212
Float Shares
41,946,709
Reddit Posts
1
News Items
1
SEC Filings
0
Data Points
250

IPA

ImmunoPrecise Antibodies Ltd.
-18.78%
Price: $2.77
Confidence: 0.86
Reddit
News
Low Float
Last updated: 2025-08-20 20:06:56

Technical Analysis

RSI: 81.54 (sell)
MACD: 0.26
Technical Analysis Graph

Risk Analysis

Volatility
124.73%
Max Drawdown
-60.6%
Beta
1.0
Risk Score
94.1

Social Sentiment

90.0
Social Sentiment Score (0-100)

Recent News

News thumbnail
Simply Wall St. - 2025-07-30 10:34
ImmunoPrecise Antibodies ( NASDAQ:IPA ) Full Year 2025 Results Key Financial Results Revenue: CA$24.5m (flat on FY...

Reddit Discussions

r/pennystocks - 2025-07-24 14:38 - Score: 20 - Comments: 32
**Float**: \~43M. Total shares \~51M. Low insider and institutional ownership. Retail can punch above its weight here. **Revenue**: $6.2M last quarter. Revenue holding steady. $12.9M cash in the bank. They’re burning but not bleeding. **Revenue Streams**: * **Project Revenue**: \~$5.6M from therapeutic discovery services, including B Cell Select and LENSai-based programs * **Product Sales**: Custom antibodies and catalog reagents * **Storage and Licensing**: Biostorage, tech licensing, and su...

Recent SEC Filings

No recent SEC filings found.